Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Yates

Showing results (651-660 of 661) with videos related to

Pageof 67
Sort By:
Science Immunology|November 1, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cellsGerone A Gonzales, Song Huang, Liam Wilkinson, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
JMIR Research Protocols|May 21, 2021
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled TrialAnna M Hood, Heather Strong, Cara Nwankwo, et al.
European Journal of Human Genetics : EJHG|January 13, 2021
Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotypeMeena Balasubramanian, Alexander J M Dingemans, Shadi Albaba, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2021
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studyS K Mahil, M Yates, Z Z N Yiu, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Bioorganic & Medicinal Chemistry|October 3, 2006
Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonistsDaniel P Walker, Donn G Wishka, David W Piotrowski, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Circulation|November 16, 2017
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical PathwayMartin P Than, John W Pickering, Jeremy M Dryden, et al.
Pageof 67

Showing results (651-660 of 661) with videos related to

Sort By:
Pageof 67
Science Immunology|November 1, 2024
The pore-forming apolipoprotein APOL7C drives phagosomal rupture and antigen cross-presentation by dendritic cellsGerone A Gonzales, Song Huang, Liam Wilkinson, et al.
Nature Medicine|April 21, 2015
Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory diseaseMyriam Chimen, Helen M McGettrick, Bonita Apta, et al.
The Lancet. Haematology|December 7, 2024
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trialModupe Idowu, Lucas Otieno, Bogdan Dumitriu, et al.
JMIR Research Protocols|May 21, 2021
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled TrialAnna M Hood, Heather Strong, Cara Nwankwo, et al.
European Journal of Human Genetics : EJHG|January 13, 2021
Comprehensive study of 28 individuals with SIN3A-related disorder underscoring the associated mild cognitive and distinctive facial phenotypeMeena Balasubramanian, Alexander J M Dingemans, Shadi Albaba, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 19, 2021
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studyS K Mahil, M Yates, Z Z N Yiu, et al.
Journal of Medicinal Chemistry|July 11, 2006
Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationshipDonn G Wishka, Daniel P Walker, Karen M Yates, et al.
Bioorganic & Medicinal Chemistry|October 3, 2006
Design, synthesis, structure-activity relationship, and in vivo activity of azabicyclic aryl amides as alpha7 nicotinic acetylcholine receptor agonistsDaniel P Walker, Donn G Wishka, David W Piotrowski, et al.
The British Journal of Dermatology|December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient surveyS K Mahil, M Yates, S M Langan, et al.
Circulation|November 16, 2017
ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical PathwayMartin P Than, John W Pickering, Jeremy M Dryden, et al.
Pageof 67